Abstract
Hypertension, a major risk factor for cardiovascular disease worldwide, is increasing significantly in urbanised South Africans. Impaired glomerular filtration is a potential contributor to hypertension. Although HIV infection is widespread, little is known regarding its contribution to diminished estimated glomerular filtration rate (eGFR) and, in turn, hypertension in Africans. We compared eGFRs and cardiovascular profiles of newly identified HIV infected African men (N=53) not yet undergoing anti-retroviral therapy, and uninfected African men of similar age and anthropometry. The aim of the study was to determine whether eGFR is diminished in treatment naive HIV infected individuals and whether eGFR is associated with a potential modulator of hypertension, namely serum L-arginine. Cardiovascular risk factor profiles of HIV infected and uninfected men were similar. In men with healthy eGFRs >90 ml min−1 per 1.73 m2, eGFR was significantly lower with HIV infection (114 (90; 147)) compared with that in uninfected men: (120 (91; 168)), P=0.043. Despite the absence of clinically-diagnosed renal dysfunction, eGFR associated significantly with serum L-arginine only in HIV infected men (R2=0.277, β=−0.299, P=0.034), whereas L-arginine did not stay in the model for uninfected men. This difference suggests that the fate of L-arginine as a substrate for nitric oxide generation may be altered in HIV infected individuals. Subsequently this is likely to escalate endothelial dysfunction, contributing to later hypertension and cardiovascular disease. Our findings show that while glomerular filtration rate is not associated with L-arginine in uninfected men, it is diminished and significantly negatively associated with serum L-arginine in HIV infected men.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008; 371: 915–922.
Jolly S, Vittinghoff E, Chattopadhyay A, Bibbins-Domingo K . Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites. Am J Med 2010; 123 (9): 811–818.
Klag M, Whelton P, Randall B, Neaton J, Brancati F, Stamler J . End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997; 277: 1293–1298.
Hsu C, McCulloch C, Darbinian J, Go AS, Iribarren C . Elevated blood pressure and risk of endstage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005; 165: 923–928.
Rettig R, Folberth C, Stauss H, Kopf D, Waldherr R, Unger T . Role of the kidney in primary hypertension: a renal transplantation study in rats. Am J Physiol 1990; 258: 606–611.
Kestenbaum B, Rudser K, de Boer I, Peralata C, Fried F, Shlipak M et al. Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. Ann Intern Med 2008; 148: 501–508.
Castelli WP . Epidemiology of coronary heart disease. The Framinghan Study. Am J Med 1984; 76: 4–12.
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17 (7): 2034–2047.
Vallance P, Chan N . Endothelial function and nitric oxide: clinical relevance. Heart 2001; 85: 342–350.
Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A . Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94 (6): 1298–1303.
Schlaich M, Schmitt D, Ott C, Schmieder R . Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans. J Hypertens 2008; 26 (1): 110–116.
Böger RH . Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 2006; 38 (2): 126–136.
Closs E, Basha F, Habermeier A, Forstermann U . Interference of L-arginine analogues with L-arginine transport mediated by the y carrier hCAT-2B. Nitric Oxide 1997; 1: 65–73.
UNAIDS (2010) Sub-Saharan Africa. Aids epidemic update. Regional summary http://www.unaids.org/documents/20101123_GlobalReport_em.pdf. (accessed 18 April 2012).
Hsue P, Lo J, Franklin A, Bolger A, Martin J, Deeks S et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004; 109: 1603–1608.
de Gaetano-Donati K, Rabagliati R, Iacoviello L, Cauda R . HIV infection, HAART, and endothelial adhesion molecules: current perspectives. Lancet Infect Dis 2004; 4: 213–222.
Winston J, Klotman PE . HIV-associated nephropathy. Mt Sinai J Med 1998; 65: 27–32.
Cockroft D, Gault M . Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.
Schwedhelm E, Tan-Andresen J, Maas R, Riederer U, Schulze F, Boger R . Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma. Clin Chem 2005; 51: 1268–1271.
Schwedhelm E, Maas R, Tan-Andresen J, Schulze F, Riederer U, Boger RH . High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 851: 211–219.
Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T . High-throughput spectrophotometric assay of reactive oxygen species in serum. Mut Res 2007; 631: 55–61.
Marfell-Jones M, Olds T, Stewart A, Carter L (eds). International Standards For Anthropometric Assessment. International society for the Advancement of Kinanthropometry: Potchefstroom, South Africa, 2006.
Wesseling KH, Jansen JR, Settels J, Schreuder J . Computation of aortic flow from pressure in humans using a non-linear, three-element model. J Appl Physiol 1993; 75: 2566–2573.
National Kidney Foundation. KDOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (2 Suppl 1): S1–266.
Ledwaba L, Tavel J, Khabo P, Maja P, Qin J, Sangweni P et al. Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a south african cohort with advanced HIV disease. PLoS ONE 2012; 7 (3): e24243.
Vaziri N, Ni Z, Oveisi F, Liang K, Pandian R . Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002; 39: 135–141.
Moreno-Cuerda V, Morales-Conejo M, Rubio R . Antiretroviral treatment associated life-threatening adverse events. Medicina Clinica 2006; 126 (19): 744–749.
Wu G, Morris M . Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1–17.
Lu¨neburg N, Xanthakis V, Schwedhelm E, Sullivan L, Maas R, Anderssohn M et al. Reference intervals for plasma L-Arginine and the L-Arginine:asymmetric dimethylarginine ratio in the framingham offspring cohort1–3. J Nutr 2011; 141: 2186–2190.
Genovese G, Friedman D, Ross M, Lecordier L, Uzureau P, Freedman B et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329 (5993): 841–845.
Opie L, Seedat Y . Hypertension in sub-Saharan African populations. Circulation 2005; 112: 3562–3568.
Reyes AA, Karl IE, KJahr S . Role of arginine in health and disease. Am J Physiol 1994; 267: F331–F346.
Baylis C . Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 2008; 294: F1–F9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Glyn, M., Van Rooyen, J., Schutte, R. et al. A comparison of the association between glomerular filtration and L-arginine status in HIV-infected and uninfected African men: the SAfrEIC study. J Hum Hypertens 27, 557–563 (2013). https://doi.org/10.1038/jhh.2013.14
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2013.14
Keywords
This article is cited by
-
Recent advances in understanding hypertension development in sub-Saharan Africa
Journal of Human Hypertension (2017)